| Q99617860 | A Novel Concept is Needed for Combating Alzheimer's Disease and NeuroHIV |
| Q42282888 | A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. |
| Q37779726 | A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. |
| Q45418068 | Acute exposure to ethanol potentiates human immunodeficiency virus type 1 Tat-induced Ca(2+) overload and neuronal death in cultured rat cortical neurons. |
| Q28267535 | Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G |
| Q52574472 | Applications of the FIV Model to Study HIV Pathogenesis. |
| Q42429157 | Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory |
| Q35624697 | Autophagy in dementias |
| Q33614467 | Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals |
| Q37425262 | CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection |
| Q36844731 | Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. |
| Q35945472 | Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat. |
| Q40689880 | Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons |
| Q35215063 | Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury |
| Q48496328 | Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain |
| Q37092361 | Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study |
| Q47432196 | Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters. |
| Q37858336 | Endoplasmic-reticulum calcium depletion and disease |
| Q36402588 | Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope |
| Q58549748 | Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy |
| Q43051856 | Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons |
| Q27023968 | HIV Associated Neurocognitive Disorders |
| Q33882450 | HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment. |
| Q59355884 | HIV induces synaptic hyperexcitation via cGMP-dependent protein kinase II activation in the FIV infection model |
| Q34795283 | HIV neurotoxicity: potential therapeutic interventions |
| Q42011853 | HIV-1 Gp120 clade B/C induces a GRP78 driven cytoprotective mechanism in astrocytoma. |
| Q27487322 | HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization |
| Q38747519 | HIV-1 Tat Promotes Lysosomal Exocytosis in Astrocytes and Contributes to Astrocyte-mediated Tat Neurotoxicity |
| Q28261913 | HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase |
| Q36634476 | HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions |
| Q37006276 | HIV-1 Transgenic Rat Prefrontal Cortex Hyper-Excitability is Enhanced by Cocaine Self-Administration |
| Q27473387 | HIV-1 associated dementia: symptoms and causes |
| Q40107899 | HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-kappaB-dependent mechanism |
| Q36438349 | HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway |
| Q40717315 | HIV-1 gp120-Mediated Mitochondrial Dysfunction and HIV-Associated Neurological Disorders |
| Q36558451 | HIV-1 gp120Bal down-Regulates Phosphorylated NMDA Receptor Subunit 1 in Cortical Neurons via Activation of Glutamate and Chemokine Receptors |
| Q36010129 | HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders |
| Q47550748 | HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses |
| Q42153636 | Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells |
| Q92443990 | Host Calcium Channels and Pumps in Viral Infections |
| Q39427767 | Human Immunodeficiency Virus Promotes Mitochondrial Toxicity |
| Q37183208 | Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death |
| Q37319262 | Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways |
| Q45399758 | Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. |
| Q38122650 | Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways |
| Q36788754 | Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal-specific tubulin |
| Q40090533 | Importance of Autophagy in Mediating Human Immunodeficiency Virus (HIV) and Morphine-Induced Metabolic Dysfunction and Inflammation in Human Astrocytes |
| Q36409179 | Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells |
| Q35783846 | Infectious agents and age-related neurodegenerative disorders |
| Q37848266 | Infectious agents and neurodegeneration |
| Q47786283 | Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons. |
| Q37399037 | Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors. |
| Q36915824 | Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors |
| Q27339182 | Interaction of paroxetine with mitochondrial proteins mediates neuroprotection |
| Q36166231 | Ketone bodies protection against HIV-1 Tat-induced neurotoxicity |
| Q37245921 | Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes |
| Q36950980 | MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function |
| Q28082139 | Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders |
| Q36166123 | Mechanisms of the blood-brain barrier disruption in HIV-1 infection |
| Q61053653 | Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy |
| Q33753132 | Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review |
| Q37462244 | Molecular pathology of neuro-AIDS (CNS-HIV). |
| Q36432328 | Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice. |
| Q28474433 | Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription |
| Q28261344 | Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions |
| Q37538776 | NanoART, neuroAIDS and CNS drug delivery |
| Q30486458 | Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures |
| Q37089861 | NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. |
| Q37721505 | Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. |
| Q37264028 | Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. |
| Q36790852 | Neuroprotective effects of tetrandrine against vascular dementia. |
| Q37547409 | Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication |
| Q35941437 | Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development. |
| Q36201412 | Opiate drug use and the pathophysiology of neuroAIDS. |
| Q35009483 | Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. |
| Q33797852 | Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis |
| Q64118578 | Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection |
| Q33605370 | Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels |
| Q35218599 | Retracted: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats |
| Q52654834 | Scaling Synapses in the Presence of HIV. |
| Q44843655 | Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat. |
| Q36295998 | T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders |
| Q30738175 | The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons |
| Q46319672 | Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. |